Search

everythinglearnresearchcommunity

for

Search:↓

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

The COVID-19 vaccine is viewed more negatively and causes more side effects than the flu vaccine in Korean patients with lupus.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

COVID-19 vaccination may be linked to MIS-C in children, highlighting the need for quick diagnosis and treatment.

Pregnant and breastfeeding women should get COVID-19 vaccines for safety and protection.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Continued vaccine and drug development is crucial due to new virus variants and regional infection spikes.

Vaccines work well in Netherton syndrome patients, similar to healthy people.

Canakinumab's effect on COVID-19 outcomes is unclear.

COVID-19 vaccines caused some side effects in the Saudi population.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

COVID-19 vaccination may trigger lupus in some people.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

People in high-income countries are more likely to accept COVID-19 booster doses than those in middle or low-income countries.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Provenge extends prostate cancer survival by about 4 months.

Some Moroccan medicinal plants may contain compounds that can inhibit the virus causing COVID-19.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.